Cargando…
Assessment of MMP-9, TIMP-1, and COX-2 in normal tissue and in advanced symptomatic and asymptomatic carotid plaques
BACKGROUND: Mature carotid plaques are complex structures, and their histological classification is challenging. The carotid plaques of asymptomatic and symptomatic patients could exhibit identical histological components. OBJECTIVES: To investigate whether matrix metalloproteinase 9 (MMP-9), tissue...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3076223/ https://www.ncbi.nlm.nih.gov/pubmed/21457581 http://dx.doi.org/10.1186/1477-9560-9-6 |
_version_ | 1782201812006207488 |
---|---|
author | V Baroncini, Liz Andréa Nakao, Lia S Ramos, Simone G Filho, Antonio Pazin Murta, Luiz Otávio Ingberman, Max Tefé-Silva, Cristiane Précoma, Dalton B |
author_facet | V Baroncini, Liz Andréa Nakao, Lia S Ramos, Simone G Filho, Antonio Pazin Murta, Luiz Otávio Ingberman, Max Tefé-Silva, Cristiane Précoma, Dalton B |
author_sort | V Baroncini, Liz Andréa |
collection | PubMed |
description | BACKGROUND: Mature carotid plaques are complex structures, and their histological classification is challenging. The carotid plaques of asymptomatic and symptomatic patients could exhibit identical histological components. OBJECTIVES: To investigate whether matrix metalloproteinase 9 (MMP-9), tissue inhibitor of MMP (TIMP), and cyclooxygenase-2 (COX-2) have different expression levels in advanced symptomatic carotid plaques, asymptomatic carotid plaques, and normal tissue. METHODS: Thirty patients admitted for carotid endarterectomy were selected. Each patient was assigned preoperatively to one of two groups: group I consisted of symptomatic patients (n = 16, 12 males, mean age 66.7 ± 6.8 years), and group II consisted of asymptomatic patients (n = 14, 8 males, mean age 67.6 ± 6.81 years). Nine normal carotid arteries were used as control. Tissue specimens were analyzed for fibromuscular, lipid and calcium contents. The expressions of MMP-9, TIMP-1 and COX-2 in each plaque were quantified. RESULTS: Fifty-eight percent of all carotid plaques were classified as Type VI according to the American Heart Association Committee on Vascular Lesions. The control carotid arteries all were classified as Type III. The median percentage of fibromuscular tissue was significantly greater in group II compared to group I (p < 0.05). The median percentage of lipid tissue had a tendency to be greater in group I than in group II (p = 0.057). The percentages of calcification were similar among the two groups. MMP-9 protein expression levels were significantly higher in group II and in the control group when compared with group I (p < 0.001). TIMP-1 expression levels were significantly higher in the control group and in group II when compared to group I, with statistical difference between control group and group I (p = 0.010). COX-2 expression levels did not differ among groups. There was no statistical correlation between MMP-9, COX-2, and TIMP-1 levels and fibrous tissue. CONCLUSIONS: MMP-9 and TIMP-1 are present in all stages of atherosclerotic plaque progression, from normal tissue to advanced lesions. When sections of a plaque are analyzed without preselection, MMP-9 concentration is higher in normal tissues and asymptomatic surgical specimens than in symptomatic specimens, and TIMP-1 concentration is higher in normal tissue than in symptomatic specimens. |
format | Text |
id | pubmed-3076223 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-30762232011-04-14 Assessment of MMP-9, TIMP-1, and COX-2 in normal tissue and in advanced symptomatic and asymptomatic carotid plaques V Baroncini, Liz Andréa Nakao, Lia S Ramos, Simone G Filho, Antonio Pazin Murta, Luiz Otávio Ingberman, Max Tefé-Silva, Cristiane Précoma, Dalton B Thromb J Original Basic Research BACKGROUND: Mature carotid plaques are complex structures, and their histological classification is challenging. The carotid plaques of asymptomatic and symptomatic patients could exhibit identical histological components. OBJECTIVES: To investigate whether matrix metalloproteinase 9 (MMP-9), tissue inhibitor of MMP (TIMP), and cyclooxygenase-2 (COX-2) have different expression levels in advanced symptomatic carotid plaques, asymptomatic carotid plaques, and normal tissue. METHODS: Thirty patients admitted for carotid endarterectomy were selected. Each patient was assigned preoperatively to one of two groups: group I consisted of symptomatic patients (n = 16, 12 males, mean age 66.7 ± 6.8 years), and group II consisted of asymptomatic patients (n = 14, 8 males, mean age 67.6 ± 6.81 years). Nine normal carotid arteries were used as control. Tissue specimens were analyzed for fibromuscular, lipid and calcium contents. The expressions of MMP-9, TIMP-1 and COX-2 in each plaque were quantified. RESULTS: Fifty-eight percent of all carotid plaques were classified as Type VI according to the American Heart Association Committee on Vascular Lesions. The control carotid arteries all were classified as Type III. The median percentage of fibromuscular tissue was significantly greater in group II compared to group I (p < 0.05). The median percentage of lipid tissue had a tendency to be greater in group I than in group II (p = 0.057). The percentages of calcification were similar among the two groups. MMP-9 protein expression levels were significantly higher in group II and in the control group when compared with group I (p < 0.001). TIMP-1 expression levels were significantly higher in the control group and in group II when compared to group I, with statistical difference between control group and group I (p = 0.010). COX-2 expression levels did not differ among groups. There was no statistical correlation between MMP-9, COX-2, and TIMP-1 levels and fibrous tissue. CONCLUSIONS: MMP-9 and TIMP-1 are present in all stages of atherosclerotic plaque progression, from normal tissue to advanced lesions. When sections of a plaque are analyzed without preselection, MMP-9 concentration is higher in normal tissues and asymptomatic surgical specimens than in symptomatic specimens, and TIMP-1 concentration is higher in normal tissue than in symptomatic specimens. BioMed Central 2011-04-03 /pmc/articles/PMC3076223/ /pubmed/21457581 http://dx.doi.org/10.1186/1477-9560-9-6 Text en Copyright ©2011 V Baroncini et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Basic Research V Baroncini, Liz Andréa Nakao, Lia S Ramos, Simone G Filho, Antonio Pazin Murta, Luiz Otávio Ingberman, Max Tefé-Silva, Cristiane Précoma, Dalton B Assessment of MMP-9, TIMP-1, and COX-2 in normal tissue and in advanced symptomatic and asymptomatic carotid plaques |
title | Assessment of MMP-9, TIMP-1, and COX-2 in normal tissue and in advanced symptomatic and asymptomatic carotid plaques |
title_full | Assessment of MMP-9, TIMP-1, and COX-2 in normal tissue and in advanced symptomatic and asymptomatic carotid plaques |
title_fullStr | Assessment of MMP-9, TIMP-1, and COX-2 in normal tissue and in advanced symptomatic and asymptomatic carotid plaques |
title_full_unstemmed | Assessment of MMP-9, TIMP-1, and COX-2 in normal tissue and in advanced symptomatic and asymptomatic carotid plaques |
title_short | Assessment of MMP-9, TIMP-1, and COX-2 in normal tissue and in advanced symptomatic and asymptomatic carotid plaques |
title_sort | assessment of mmp-9, timp-1, and cox-2 in normal tissue and in advanced symptomatic and asymptomatic carotid plaques |
topic | Original Basic Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3076223/ https://www.ncbi.nlm.nih.gov/pubmed/21457581 http://dx.doi.org/10.1186/1477-9560-9-6 |
work_keys_str_mv | AT vbaroncinilizandrea assessmentofmmp9timp1andcox2innormaltissueandinadvancedsymptomaticandasymptomaticcarotidplaques AT nakaolias assessmentofmmp9timp1andcox2innormaltissueandinadvancedsymptomaticandasymptomaticcarotidplaques AT ramossimoneg assessmentofmmp9timp1andcox2innormaltissueandinadvancedsymptomaticandasymptomaticcarotidplaques AT filhoantoniopazin assessmentofmmp9timp1andcox2innormaltissueandinadvancedsymptomaticandasymptomaticcarotidplaques AT murtaluizotavio assessmentofmmp9timp1andcox2innormaltissueandinadvancedsymptomaticandasymptomaticcarotidplaques AT ingbermanmax assessmentofmmp9timp1andcox2innormaltissueandinadvancedsymptomaticandasymptomaticcarotidplaques AT tefesilvacristiane assessmentofmmp9timp1andcox2innormaltissueandinadvancedsymptomaticandasymptomaticcarotidplaques AT precomadaltonb assessmentofmmp9timp1andcox2innormaltissueandinadvancedsymptomaticandasymptomaticcarotidplaques |